Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

57.19

+0.15 (0.26%)

as of Jun 26, 2026, 8:00:00 pm Market Open.

1634 watching

Investor Insights

Jun 27, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from experts, highlighting its strengths in capital management, particularly in Asia and wealth management. Several analysts view it as a reliable income stock, benefiting from a decent dividend yield, yet caution against its growth potential compared to Canadian banks. The company has faced short-term challenges, including mixed results from its alternative portfolio and limited growth in its U.S. operations, which has sparked some concerns. Analysts suggest waiting for opportunities to buy during pullbacks, given its valuation relative to major financials, alongside the potential for increased profitability stemming from rising interest rates. Overall, while MFC is generally recognized for its stability and improvements in earnings quality, it struggles to capture investor attention amidst recent market shifts.

Consensus

Hold

Valuation

Fair Value

Similar

SLF-T

TOP PICK

Have done a great job of de-leveraging their book from what it was like a couple of years ago. What they need now are higher equity markets and higher interest rates. As interest rates go down, they lose money.

Wealthica Track your Stocks in your Watch List

PAST TOP PICK

(A Top Pick Nov 22/10. Down 13.68%.) Sold her holdings at about $17.

BUY

Have put together 3 quarters in a row where they have started to turn around. Finally getting their act together. Great international growth. Well-positioned domestically in North America. Have controlled the market leverage much better.

DON'T BUY

Yield isn't too bad but there is still a bit of a cloud over it. Last quarterly results were excellent and they are working their way out of their problems. Certain amount of market exposure to some of their products. He would prefer Sun Life (SLF-T) or Great West (GWO-T).

DON'T BUY

Now is not the entry point. This is not where an investor should be. It is a value trap. There are a lot of issues that have to be worked out

BUY

Just reported great earnings, quite a bit better than the consensus was looking for. Well-positioned in Canada, US and Asia. Once they get beyond the current market conditions, you'll see the growth of the business lead to much higher multiples. Good value.

DON'T BUY

Good numbers in Q2, which they badly needed. Normally they do a readjustment to their actuarial assumptions in Q3 and that could be a one-time charge that will be material for them. He would watch for what that is before he would be comfortable with this as a long-term hold.

COMMENT

Had better than expected earnings but everyone is focused on interest rates and how they are hedged on them. Lower interest rates are bad for their earnings going forward. The underlying business is doing very well. At some point, interest rates will go up and this company will recover.

SELL

Held this for a long time but finally sold it recently. Equity risks are now being covered because they are now putting on more hedging. The big drop in bond yields has hurt insurance companies. Dynamics are poor.

BUY

Good time to load up. Sales are tremendous. Exposure to Asia is a good thing. Problem is the investment portfolio and sins of the past. Will be one of the better performing financial stocks in Canada. Non-bank financials are the place to be.

HOLD

It looks like the stock will come back into the $10 range. Last year the company said they needed 2 things for their business plan. They needed both the stock market and interest rates to go up.

PAST TOP PICK

(A Top Pick Aug 19/10. Up 15.38%.) Chart shows a low in 09 and another one in 2010 but the second one was a higher low. Has been dropping in 2011 because of QE2, which has put pressure on interest rates. Keep an eye on the US 10 year and watch for the yield to get back up through 3%, 3.5% and so on. Still a Hold.

COMMENT

This is a good entry point for someone with a 2-year outlook. Has a lot of sensitivity to the marketplace and interest rates. New management has worked to hedge this more. Doesn't expect they will have a very good quarter and continued market volatility will impact the earnings.

DON'T BUY

Not a fan. Doesn't like the US operations, which hurt them very badly in the last downturn. There huge acquisition of John Hancock hasn't really worked out that well. Still likes their Far East prospects and their Canadian operations.

WATCH

Was probably the most leveraged company to the stock and bond market coming of 2008. Have done an incredibly good job of de-leveraging in the last two years. Sees some decent upside potential. He has a $19 target, but is a little nervous on this given where interest rates and where the stock market has gone. $19 would be 18-24 months. Next quarter could be a little dicey for them.

Showing 1,276 to 1,290 of 2,281 entries

Most Recent Experts

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Kevin Simpson

Capital Wealth Planning

Bryn Talkington

Requisite Capital Management

Andrey Omelchak

LionGuard Capital Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)